Carr

$ACAD buy buy buy

Long
NASDAQ:ACAD   ACADIA Pharmaceuticals Inc.
2
No-brainer off the double bottom with breakout pending.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.